Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.

Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Reis M, Geffel KM, Nowalk MP, DaSilva J, Keong LM, Stark TJ, Barnes JR, Wentworth DE, Brammer L, Burns E, Fry AM, Patel MM, Flannery B
MMWR Morb Mortal Wkly Rep. 2022 71 (10): 365-370

PMID: 35271561 · PMCID: PMC8911998 · DOI:10.15585/mmwr.mm7110a1

MeSH Terms (19)

Adolescent Adult Aged Child Child, Preschool Humans Infant Influenza, Human Influenza A virus Influenza A Virus, H1N1 Subtype Influenza A Virus, H3N2 Subtype Influenza B virus Influenza Vaccines Middle Aged Population Surveillance Seasons United States Vaccination Vaccine Efficacy

Connections (1)

This publication is referenced by other Labnodes entities:

Links